COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,672 Articles (22,913 medRxiv, 8,759 bioRxiv)

Most recent first Previous |  Page 279: Articles 2781-2790  | Next

How do we respond to the next SARS CoV epidemic/pandemic? A bioinformatics approach with the promise of preventing or reducing the severity of future SARS CoV related pandemics
Geoffrey A S, B., Gracia, J.
10.1101/2024.03.22.586249 — Posted: 2024-03-25
Enhancing COVID-19 Forecasting Precision through the Integration of Compartmental Models, Machine Learning and Variants
Baccega, D., Castagno, P., Fernandez Anta, A., Sereno, M.
10.1101/2024.03.20.24304583 — Posted: 2024-03-24
Effectiveness of COVID-19 Vaccines: A Vaccinated-Only Approach
Foppa, I. M.
10.1101/2024.03.23.24304769 — Posted: 2024-03-24
Persistence of S1 Spike Protein in CD16+ Monocytes up to 245 Days in SARS-CoV-2 Negative Post COVID-19 Vaccination Individuals with Post-Acute Sequalae of COVID-19 (PASC)-Like Symptoms
Yogendra, R., Patterson, B. K., Francisco, B., Long, E., Pise, A., Osgood, E., Bream, J., Kreimer, M., Jeffers, D., Beaty, C., Vander Heide, R., Guevara, J., Mora-Rodriguez, R.
10.1101/2024.03.24.24304286 — Posted: 2024-03-24
Mathematical models of COVID-19 vaccination in high-income countries: A systematic review
Burch, E., Aijaz Khan, S., Stone, J., Asgharzadeh, A., Dawe, J., Ward, Z., Brooks-Pollock, E., Christensen, H.
10.1101/2024.03.24.24304676 — Posted: 2024-03-24
Broad immunogenicity to prior SARS-CoV-2 strains and JN.1 variant elicited by XBB.1.5 vaccination in nursing home residents
Abul, Y., Nugent, C., Vishnepolskiy, I., Wallace, T., Dickerson, E., Holland, L., Esparza, I., Winkis, L., Wali, K. T., Chan, P. A., Baier, R. R., Recker, A., Kaczynski, M., Kamojjala, S., Pralea, A., Rice, H., Osias, O., Oyebanji, O. A., Olagunju, O., Cao, Y., Jung, C., Roederer, A., Pfeifer, W. M., King, C. L., Nanda, A., McNicoll, L., Mujahid, N., Raza, S., Tyagi, R., Wilson, B. M., White, E. M., Canaday, D. H., Gravenstein, S., Balazs, A. B.
10.1101/2024.03.21.24303684 — Posted: 2024-03-24
Psychological distress after COVID-19 recovery and subsequent prolonged post-acute sequelae of COVID-19: A longitudinal study with 1-year follow-up in Japan.
Hazumi, M., Kataoka, M., Narita, Z., Usuda, K., Nishi, D.
10.1101/2024.03.21.24304702 — Posted: 2024-03-24
A human commons cell atlas reveals cell type specificity for OAS1 isoforms
Galvez-Merchan, A., Booeshaghi, A. S., Pachter, L.
10.1101/2024.03.23.586412 — Posted: 2024-03-24
Greater Role of Cognitive Impairment Over Fatigue in Post-COVID-19 Quality of Life: A Post-Hoc Analysis of a Randomized Controlled Trial
Kwan, A. T. H., Lakhani, M., Le, G. H., Singh, G., Teopiz, K. M., Guo, Z., Ceban, F., Dhaliwal, K. K., Badulescu, S., Ho, R., Rhee, T. G., Cao, B., d'Andrea, G., McIntyre, R. S.
10.1101/2024.03.20.24304411 — Posted: 2024-03-22
Predictive validity of the simplified Radiographic Assessment of Lung Edema score for the mortality in critically ill COVID-19 patients with the B.1.617.2 (Delta) variant in Vietnam: a single-centre, cross-sectional study
Do, S. N., Dang, T. Q., Luong, C. Q., Nguyen, M. H., Pham, D. T., Nguyen, V. K., Do, T. D., Nguyen, T. Q., Nong, V. M., Vo, K. H., Nguyen, T. C., Khuat, N. H., Pham, Q. T., Hoang, D. T., Nguyen, A. D., Nguyen, P. M., Cao, D. D., Pham, D. T., Dang, D. T., Nguyen, D. T., Nguyen, V. D., Le, T. Q., Ngo, H. D., Nguyen, D. V., Pham, T. T., Nguyen, D. T., Nguyen, N. T., Huynh, N. T., Phan, N. T., Nguyen, C. D., Vu, T. T., Do, C. D., Nguyen, C. V., Vu, G. V., Dao, C. X.
10.1101/2024.03.20.24304599 — Posted: 2024-03-22

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).